Fennec Pharmaceuticals, Inc. (FENC)
6.30
-0.20
(-3.08%)
USD |
NASDAQ |
Apr 16, 16:00
6.30
0.00 (0.00%)
Pre-Market: 20:00
Fennec Pharmaceuticals EPS Diluted (Quarterly) : -0.165 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | -0.1734 |
| Gossamer Bio, Inc. | -0.2085 |
| REGENXBIO, Inc. | -1.298 |
| Zymeworks, Inc. | -0.547 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.144M |
| Revenue (Quarterly) | 13.78M |
| Total Expenses (Quarterly) | 18.92M |
| Enterprise Value | 180.41M |
| Gross Profit Margin (Quarterly) | 87.20% |
| Profit Margin (Quarterly) | -37.34% |
| Earnings Yield | -5.46% |
| Normalized Earnings Yield | -4.740 |